Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Business Times.
Press releases published on August 12, 2025
LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth
GlobeNewswire
·
August 12, 2025
LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the Company), a provider of personal safety, personal emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, …
Inspirato Reports Q2 Financial and Operating Results
GlobeNewswire
·
August 12, 2025
DENVER, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results for the second quarter (“Q2 2025”) ended June 30, 2025. …
Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
Increased revenues by 157% to $1.8 million, compared with $0.7 million for the fiscal quarter ended June 30, 2024 Awarded a national group purchasing agreement for therapeutic gases by Premier, Inc., which has more than 4,350 member hospitals and health …
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and …
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Presented three abstracts at American Society of Gene …
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T cell- …
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
-- Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $184 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current operating plan into H2 2027 -- BERKELEY, Calif., Aug. …
Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
– Presented and published the positive results from both the Launch-HTN and Advance-HTN pivotal trials at scientific meetings and in JAMA and NEJM – – Pre-NDA meeting scheduled to take place in 4Q 2025 – – Explore-CKD Phase 2 trial successfully achieved …
Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2025 Results
GlobeNewswire
·
August 12, 2025
Revenue: $8.2 million, 59% YoY increase Net Income: $13.4 million New accounts up over 233% YoY and transaction volumes up 124% YoY Successfully secured $250 million equity purchase facility 1 Bitcoin Investment Treasury Holdings: 1,492 BTC PHOENIX, Aug. …
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025 Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline …
NEXGEL Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Second quarter 2025 revenue totaled $2.88 million, an increase of 100.3% as compared to $1.44 million for the same period year-over-year Gross Profit for the quarter was 43.6%, compared to 20.3% for the same period in 2024 Company is reiterating revenue …
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
MELVILLE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial …
SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and Canadian Markets
GlobeNewswire
·
August 12, 2025
Company reports $15.7 million in cash, cash equivalents, and restricted cash, as compared to $12.3 million as of March 31, 2025. SKYX Continues to Leverage its Cash Position Through its E-Commerce Platform of 60 Websites among Other Methods Including …
Highwoods Recasts Term Loan
GlobeNewswire
·
August 12, 2025
RALEIGH, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has executed a recast of a $200 million unsecured bank term loan by extending the maturity date from May 2026 to January 2029. The term can be extended for two …
Playboy Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Q2 Revenue of $28.1 Million, up 13% Year-over-Year; Net Loss of $7.7 Million, an Improvement of $9.0 Million; Adjusted EBITDA of $3.5 Million, an Improvement of $6.4 Million LOS ANGELES, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ: PLBY) (the “ …
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 12, 2025
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced strategic research collaboration and …
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 12, 2025
Randomized 3-month REMAIN-1 Midpoint Cohort data expected in September 2025 Positive 3-month REVEAL-1 Cohort data showed single Revita® procedure sustained weight loss after GLP-1 discontinuation; incremental 6-month open-label data expected in Q4 2025 Top …
Slide Reports Second Quarter 2025 Results
GlobeNewswire
·
August 12, 2025
- Gross Premiums Written Increased 25.0% Year-over-Year to $435.4 Million - - Net Income Grew 30.5% Year-over-Year to $70.1 Million; $0.56 Diluted Earnings Per Share - - Combined Ratio Improved 250 Basis Points Year-over-Year to 67.4% - - Completed Initial …
WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Delivered Revenue and Adjusted EBITDA above the top end of Guidance Ranges Second Quarter Revenue Growth of 8.5%; Revenue Growth on a Constant Currency Basis of 5.5% Net Loss of $3.9 Million; Adjusted EBITDA of $9.7 Million Strong Balance Sheet With Cash …
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
GlobeNewswire
·
August 12, 2025
Reported potentially best-in-class clinical efficacy and safety data from ongoing Phase 1b trial of ORIC-944 in combination with AR inhibitors for the treatment of patients with mCRPC Strengthened cash position with $244 million gross proceeds from top- …